STATLIA MATRIX
STATLIA MATRIX is an enterprise bioanalytical software platform designed for regulated biopharmaceutical laboratories performing ELISA, relative potency, and immunogenicity assays.
Publisher review
STATLIA MATRIX is an enterprise bioanalytical software platform designed for regulated biopharmaceutical laboratories performing ELISA, relative potency, and immunogenicity assays. It serves pharmaceutical companies, biotech firms, and clinical research organizations needing standardized assay processes with regulatory compliance. The software incorporates advanced statistical models while managing complex workflow requirements in multi-user environments.
Its core user base consists of labs requiring reproducible, auditable analysis for drug development and quality control. The platform's key capabilities include 5PL and 4PL curve fitting for bioassay analysis, automated weighting computations, and Monte Carlo methods for confidence interval estimation. It tracks metrics like optimal dilution doses, signal saturation, and assay behavior shifts from reagent lot changes.
The system establishes response limits for standard dilutions and generates automated reports with graphs, metrics, and acceptance limits. Deployment options include LAN, cloud, and Citrix environments, supporting collaborative workflows across distributed teams. STATLIA MATRIX competes with broader LIMS platforms but specializes in assay-specific analytics lacking in generic systems.
Unlike ELN-centric competitors, it combines statistical rigor with assay lifecycle management. The software's peer-reviewed methodologies (cited 400+ times) give it credibility in regulated environments. However, it faces challenges from larger vendors offering end-to-end lab informatics.
The transition from STATLIA 3.2 creates legacy support burdens, and the lack of disclosed pharma partnerships limits market visibility. While feature-rich for immunoassays, it may require integration with other systems for full lab operations.
How it works
-
5PL/4PL curve fitting
Implements gold-standard logistic models for bioassay analysis, including peer-reviewed Five Parameter Logistic methodology cited in 400+ publications
-
Assay behavior monitoring
Automatically detects test behavior shifts caused by reagent lot changes or protocol differences, tracking pooled assays and standard dilution responses
-
Enterprise deployment options
Supports multi-user environments through LAN, cloud, and Citrix deployments with centralized workflow management
-
Regulatory reporting
Generates automatic compliance reports including graphs, metrics, ranges, and acceptance limits for audit trails
-
Relative potency analysis
Provides Chi-Square and Equivalence Methods for Parallelism assays with Monte Carlo confidence interval estimation
-
Dose-range optimization
Tracks optimal dilution doses, usable dose ranges, and signal saturation points for assay development
-
Legacy system support
Maintains compatibility pathways for customers transitioning from STATLIA 3.2 platform
Strengths and trade-offs
Strengths
- Peer-reviewed 5PL curve fitting methodology has been cited in over 400 scientific publications, establishing analytical credibility.
- Supports three deployment models (LAN, cloud, Citrix) uncommon among specialized bioanalytical software competitors.
- Automates 23 distinct assay metrics including dilution response limits and lot-change detection that typically require manual tracking.
- Provides both equivalence and chi-square methods for parallelism analysis in relative potency assays, a rare dual-methodology approach.
Trade-offs
- No public disclosures of enterprise contracts with top-20 pharma companies as of 2023 sources.
- Legacy STATLIA 3.2 support may divert resources from MATRIX platform development per transition challenges noted in documentation.
- Lacks native integration with common LIMS platforms, requiring manual data transfer for full lab workflows.
- Pricing transparency issues with no publicly available tier structure or cost benchmarks versus competitors.
Pricing context
Enterprise pricing not publicly disclosed; requires direct consultation for cloud, LAN, or virtualized deployment quotes
Getting started with STATLIA MATRIX
-
Request demo access
Contact STATLIA MATRIX sales to request a demo or trial version. Provide your organization details and intended use case for bioanalytical workflows.
-
Deploy infrastructure
Choose between LAN, cloud, or Citrix deployment based on your IT environment. Install server components or configure cloud instance as directed by vendor documentation.
-
Import assay data
Load existing ELISA or immunogenicity assay results in supported formats. Map your data columns to STATLIA MATRIX's analysis parameters for curve fitting.
-
Configure 5PL model
Set up Five Parameter Logistic curve fitting with automated weighting. Define acceptance criteria for potency assays based on your regulatory requirements.
-
Generate compliance report
Run analysis to produce automated reports with graphs, metrics, and acceptance limits. Schedule recurring reports for ongoing assay monitoring.
Frequently Asked Questions
What is STATLIA MATRIX used for?
STATLIA MATRIX is enterprise bioanalytical software for regulated labs performing ELISA, immunogenicity, and relative potency assays. It standardizes processes with 5PL/4PL curve fitting, automated reporting, and compliance features. Pharmaceutical and biotech labs use it for reproducible drug development analytics across LAN, cloud, or Citrix environments.
How does STATLIA MATRIX handle regulatory compliance?
The platform generates automated compliance reports with graphs, metrics, and acceptance limits for audits. Its peer-reviewed 5PL methodology (cited 400+ times) meets rigorous standards. Features like assay behavior monitoring and dilution tracking provide auditable data trails for pharmaceutical quality control processes.
What deployment options does STATLIA MATRIX offer?
STATLIA MATRIX supports three deployment models: local area networks (LAN), cloud environments, and Citrix virtualization. This flexibility enables collaborative workflows across distributed teams while maintaining centralized control. Multi-user management is built in for regulated environments requiring access controls and version tracking.
How does STATLIA MATRIX compare to LIMS platforms?
Unlike generic LIMS systems, STATLIA MATRIX specializes in assay-specific analytics with advanced features like Monte Carlo confidence intervals and dual parallelism methods. However, it lacks native LIMS integration, potentially requiring additional systems for full lab operations beyond bioassay analysis.
What are the limitations of STATLIA MATRIX?
The platform has limited public pricing transparency and no disclosed partnerships with top pharma firms. Legacy support for STATLIA 3.2 may impact development resources. While strong for immunoassays, manual data transfers are needed for integration with other lab systems.
Does STATLIA MATRIX support relative potency assays?
Yes, it provides specialized tools for relative potency analysis including Chi-Square and Equivalence Methods for Parallelism assays. The software calculates Monte Carlo confidence intervals and tracks optimal dilution doses, addressing key requirements for biopharmaceutical potency testing in regulated environments.
Alternatives
How STATLIA MATRIX compares
Direct head-to-head against 2 competitors. Picked by 7wData.
STATLIA MATRIX
- Pricing
- Enterprise pricing not publicly disclosed; requires direct consultation for cloud, LAN, or virtualized deployment quotes
- Target
- STATLIA MATRIX is an enterprise bioanalytical software platform designed for regulated biopharmaceutical laboratories performing ELISA, relative potency, and immunogenicity assays.
- Strength
- Peer-reviewed 5PL curve fitting methodology has been cited in over 400 scientific publications, establishing analytical credibility.
- Watch for
- No public disclosures of enterprise contracts with top-20 pharma companies as of 2023 sources.
SoftMax Pro
- Pricing
- Custom/Contact sales
- Target
- Bioanalytical labs running ELISA and multiplex assays
- Deployment
- Windows, cloud
- Strength
- Industry-standard for plate reader data analysis with GLP compliance
- Watch for
- Steep learning curve for advanced features
GraphPad Prism
- Pricing
- $99/month or $695 perpetual
- Target
- Researchers analyzing bioassay data
- Deployment
- Windows, macOS
- Strength
- Flexible curve fitting (4PL/5PL) with publication-quality graphs
- Watch for
- Limited multiplex-specific workflows vs STATLIA
User reviews
No user reviews yet. Be the first to write one.
Sources
Reporting on this tool draws on these publicly available sources.